Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
Public ClinicalTrials.gov record NCT07458269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to determine the effects of ribupatide administered by subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.
Study identification
- NCT ID
- NCT07458269
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 264 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 3, 2026
- Primary completion
- Apr 30, 2027
- Completion
- May 31, 2027
- Last update posted
- Jul 14, 2026
2026 – 2027
United States locations
- U.S. sites
- 35
- U.S. states
- 16
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kailera Clinical Site | Mesa | Arizona | 85213 | — |
| Kailera Clinical Site | Sun City West | Arizona | 85375 | — |
| Kailera Clinical Site | Irvine | California | 92614 | — |
| Kailera Clinical Site | Lake Forest | California | 92630 | — |
| Kailera Clinical Site | Lomita | California | 90717 | — |
| Kailera Clinical Site | Long Beach | California | 90815 | — |
| Kailera Clinical Site | Montclair | California | 91763 | — |
| Kailera Clinical Site | Rolling Hills Estates | California | 90274 | — |
| Kailera Clinical Site | San Diego | California | 92103 | — |
| Kailera Clinical Site | Santa Ana | California | 92704 | — |
| Kailera Clinical Site | Van Nuys | California | 91405 | — |
| Kailera Clinical Site | DeLand | Florida | 32720 | — |
| Kailera Clinical Site | Orlando | Florida | 32801 | — |
| Kailera Clinical Site | Orlando | Florida | 32803 | — |
| Kailera Clinical Site | The Villages | Florida | 32162 | — |
| Kailera Clinical Site | Decatur | Georgia | 30030 | — |
| Kailera Clinical Site | Woodstock | Georgia | 30189 | — |
| Kailera Clinical Site | Morton | Illinois | 61550 | — |
| Kailera Clinical Site | Indianapolis | Indiana | 46254 | — |
| Kailera Clinical Site | Louisville | Kentucky | 40213 | — |
| Kailera Clinical Site | Rockville | Maryland | 20852 | — |
| Kailera Clinical Site | St Louis | Missouri | 63141 | — |
| Kailera Clinical Site | Lincoln | Nebraska | 68516 | — |
| Kailera Clinical Site | Omaha | Nebraska | 68144 | — |
| Kailera Clinical Site | East Syracuse | New York | 13057 | — |
| Kailera Clinical Site | Greensboro | North Carolina | 27405 | — |
| Kailera Clinical Site | Monroe | North Carolina | 28112 | — |
| Kailera Clinical Site | Raleigh | North Carolina | 27612 | — |
| Kailera Clinical Site | Greenville | South Carolina | 29607 | — |
| Kailera Clinical Site | Myrtle Beach | South Carolina | 29572 | — |
| Kailera Clinical Site | Knoxville | Tennessee | 37909 | — |
| Kailera Clinical Site | Memphis | Tennessee | 38119 | — |
| Kailera Clinical Site | Garland | Texas | 75043 | — |
| Kailera Clinical Site | San Antonio | Texas | 78215 | — |
| Kailera Clinical Site | Winchester | Virginia | 22601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07458269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07458269 live on ClinicalTrials.gov.